Clinical Trial Update: Biomarkers for Cognitive Decline in Intracerebral Hemorrhage

View source ↗

Summary

A clinical trial is actively recruiting to study biomarkers for cognitive decline after primary intracerebral hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intracerebral Hemorrhage

Snippet

Sponsor: Rush University Medical Center | Conditions: Primary Intracerebral Hemorrhage | Status: RECRUITING